Global Meningococcal Infections Vaccine Market Research Report 2021
- Published Date: 2021-04-15
- Report ID: 93185
- Pages: 159
-
Format:
Prudent Markets Predicts that Meningococcal Infections Vaccine Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Meningococcal Infections Vaccine Market Overview:
Global Meningococcal Infections Vaccine Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Meningococcal Infections Vaccine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Meningococcal Infections Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Meningococcal Infections Vaccine market in 2020.
Global Meningococcal Infections Vaccine Market Segmentation
By Type, Meningococcal Infections Vaccine market has been segmented into:
Meningococcal conjugate vaccines
Meningococcal polysaccharide vaccine
Serogroup B meningococcal vaccine
By Application, Meningococcal Infections Vaccine market has been segmented into:
For Children
For Preteens/Teens
For Adults
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Meningococcal Infections Vaccine market are:
Sanofi-Pasteur
Beijing Tiantan Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Hualan Biological Engineering
Chongqing Zhifei Biological Products
Zhejiang Tianyuan Bio-Pharmaceutical
Walvax Biotechnology
Royal(Wuxi) Bio-Pharmaceutical
1. Market Overview of Meningococcal Infections Vaccine
1.1 Meningococcal Infections Vaccine Market Overview
1.1.1 Meningococcal Infections Vaccine Product Scope
1.1.2 Market Status and Outlook
1.2 Meningococcal Infections Vaccine Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Meningococcal Infections Vaccine Historic Market Size by Regions (2015-2020)
1.4 Meningococcal Infections Vaccine Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Meningococcal Infections Vaccine Sales Market by Type (2015-2026)
2.1 Global Meningococcal Infections Vaccine Historic Market Size by Type (2015-2020)
2.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2021-2026)
2.3 Meningococcal conjugate vaccines
2.4 Meningococcal polysaccharide vaccine
2.5 Serogroup B meningococcal vaccine
3. Covid-19 Impact Meningococcal Infections Vaccine Sales Market by Application (2015-2026)
3.1 Global Meningococcal Infections Vaccine Historic Market Size by Application (2015-2020)
3.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2021-2026)
3.3 For Children
3.4 For Preteens/Teens
3.5 For Adults
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Meningococcal Infections Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Meningococcal Infections Vaccine Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Meningococcal Infections Vaccine Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Meningococcal Infections Vaccine Business
5.1 Sanofi-Pasteur
5.1.1 Sanofi-Pasteur Company Profile
5.1.2 Sanofi-Pasteur Meningococcal Infections Vaccine Product Specification
5.1.3 Sanofi-Pasteur Meningococcal Infections Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Beijing Tiantan Biological Products
5.2.1 Beijing Tiantan Biological Products Company Profile
5.2.2 Beijing Tiantan Biological Products Meningococcal Infections Vaccine Product Specification
5.2.3 Beijing Tiantan Biological Products Meningococcal Infections Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Wuhan Institute of Biological Products
5.3.1 Wuhan Institute of Biological Products Company Profile
5.3.2 Wuhan Institute of Biological Products Meningococcal Infections Vaccine Product Specification
5.3.3 Wuhan Institute of Biological Products Meningococcal Infections Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Lanzhou Institute of Biological Products
5.4.1 Lanzhou Institute of Biological Products Company Profile
5.4.2 Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Product Specification
5.4.3 Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Hualan Biological Engineering
5.5.1 Hualan Biological Engineering Company Profile
5.5.2 Hualan Biological Engineering Meningococcal Infections Vaccine Product Specification
5.5.3 Hualan Biological Engineering Meningococcal Infections Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Chongqing Zhifei Biological Products
5.6.1 Chongqing Zhifei Biological Products Company Profile
5.6.2 Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Product Specification
5.6.3 Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Zhejiang Tianyuan Bio-Pharmaceutical
5.7.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Profile
5.7.2 Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Product Specification
5.7.3 Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Walvax Biotechnology
5.8.1 Walvax Biotechnology Company Profile
5.8.2 Walvax Biotechnology Meningococcal Infections Vaccine Product Specification
5.8.3 Walvax Biotechnology Meningococcal Infections Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Royal(Wuxi) Bio-Pharmaceutical
5.9.1 Royal(Wuxi) Bio-Pharmaceutical Company Profile
5.9.2 Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Product Specification
5.9.3 Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Meningococcal Infections Vaccine Market Size (2015-2026)
6.2 North America Meningococcal Infections Vaccine Key Players in North America (2015-2020)
6.3 North America Meningococcal Infections Vaccine Market Size by Type (2015-2020)
6.4 North America Meningococcal Infections Vaccine Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Meningococcal Infections Vaccine Market Size (2015-2026)
7.2 East Asia Meningococcal Infections Vaccine Key Players in North America (2015-2020)
7.3 East Asia Meningococcal Infections Vaccine Market Size by Type (2015-2020)
7.4 East Asia Meningococcal Infections Vaccine Market Size by Application (2015-2020)
8. Europe
8.1 Europe Meningococcal Infections Vaccine Market Size (2015-2026)
8.2 Europe Meningococcal Infections Vaccine Key Players in North America (2015-2020)
8.3 Europe Meningococcal Infections Vaccine Market Size by Type (2015-2020)
8.4 Europe Meningococcal Infections Vaccine Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Meningococcal Infections Vaccine Market Size (2015-2026)
9.2 South Asia Meningococcal Infections Vaccine Key Players in North America (2015-2020)
9.3 South Asia Meningococcal Infections Vaccine Market Size by Type (2015-2020)
9.4 South Asia Meningococcal Infections Vaccine Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Meningococcal Infections Vaccine Market Size (2015-2026)
10.2 Southeast Asia Meningococcal Infections Vaccine Key Players in North America (2015-2020)
10.3 Southeast Asia Meningococcal Infections Vaccine Market Size by Type (2015-2020)
10.4 Southeast Asia Meningococcal Infections Vaccine Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Meningococcal Infections Vaccine Market Size (2015-2026)
11.2 Middle East Meningococcal Infections Vaccine Key Players in North America (2015-2020)
11.3 Middle East Meningococcal Infections Vaccine Market Size by Type (2015-2020)
11.4 Middle East Meningococcal Infections Vaccine Market Size by Application (2015-2020)
12. Africa
12.1 Africa Meningococcal Infections Vaccine Market Size (2015-2026)
12.2 Africa Meningococcal Infections Vaccine Key Players in North America (2015-2020)
12.3 Africa Meningococcal Infections Vaccine Market Size by Type (2015-2020)
12.4 Africa Meningococcal Infections Vaccine Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Meningococcal Infections Vaccine Market Size (2015-2026)
13.2 Oceania Meningococcal Infections Vaccine Key Players in North America (2015-2020)
13.3 Oceania Meningococcal Infections Vaccine Market Size by Type (2015-2020)
13.4 Oceania Meningococcal Infections Vaccine Market Size by Application (2015-2020)
14. South America
14.1 South America Meningococcal Infections Vaccine Market Size (2015-2026)
14.2 South America Meningococcal Infections Vaccine Key Players in North America (2015-2020)
14.3 South America Meningococcal Infections Vaccine Market Size by Type (2015-2020)
14.4 South America Meningococcal Infections Vaccine Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Meningococcal Infections Vaccine Market Size (2015-2026)
15.2 Rest of the World Meningococcal Infections Vaccine Key Players in North America (2015-2020)
15.3 Rest of the World Meningococcal Infections Vaccine Market Size by Type (2015-2020)
15.4 Rest of the World Meningococcal Infections Vaccine Market Size by Application (2015-2020)
16 Meningococcal Infections Vaccine Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
